Ardea biosciences, inc. – product pipeline review – 2012


Published on

2012 || Ardea Biosciences, Inc. – Product Pipeline Review – 2012 || Market Research

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Ardea biosciences, inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Ardea Biosciences, Inc. – Product Pipeline Review – 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - ProductPipeline Review - 2012” provides data on the Ardea Biosciences, Inc.’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Ardea Biosciences, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from Ardea Biosciences,Inc. and industry-specific third party sources, put together by Global MarketsDirect’s team.Scope- Ardea Biosciences, Inc. - Brief Ardea Biosciences, Inc. overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Ardea Biosciences, Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:
  2. 2. List of Tables 4List of Figures 4Ardea Biosciences, Inc. Snapshot 5Ardea Biosciences, Inc. Overview 5Key Information 5Key Facts 5Ardea Biosciences, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Ardea Biosciences, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Pipeline Products – Combination Treatment Modalities 10Ardea Biosciences, Inc. – Pipeline Products Glance 11Ardea Biosciences, Inc. – Late Stage Pipeline 11Phase III Products/Combination Treatment Modalities 11Ardea Biosciences, Inc. Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Phase I Products/Combination Treatment Modalities 13Ardea Biosciences, Inc. – Early Stage Pipeline Products 14Pre-Clinical Products/Combination Treatment Modalities 14Ardea Biosciences, Inc. – Drug Profiles 15900 Series 15Product Description 15Mechanism of Action 15R&D Progress 15RDEA3170 16Product Description 16Mechanism of Action 16R&D Progress 16RDEA594 17Product Description 17Mechanism of Action 17R&D Progress 17
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1Ardea Biosciences, Inc. – Product Pipeline Review – 2012Astellas Pharma Inc. – Product Pipeline Review – 2012Bayer AG – Product Pipeline Review – 2012BioLineRx, Ltd. – Product Pipeline Review – 2012Cytokinetics, Incorporated – Product Pipeline Review – 2012Meda AB – Product Pipeline Review – 2012Medivir AB – Product Pipeline Review – 2012Nektar Therapeutics – Product Pipeline Review – 2012Novo Nordisk A/S – Product Pipeline Review – 2012SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
  4. 4. Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: